Chantal Pichon

Team: ART-ARNm Affiliation: Inserm US-55, Orléans Presentation title: To be defined

Chantal Pichon is a professor at the University of Orléans (France), holder of the Chair of Innovation Excellence at the Institut Universitaire de France (Paris) and appointed guest professor at La Charité Berlin Institute of Health. She leads interdisciplinary projects at the interface of chemistry and biology.
‍
Over the past decade, she has been particularly interested in mRNA-based vaccines and therapies and is developing innovative formulations for vaccination, cell therapy and protein replacement therapy.
‍
Chantal Pichon has patented mRNA bioproduction technology, a complete paradigm shift from in vitro production and a revolutionary new use of yeast as a cell factory. It plans to build an economically sustainable biotechnology process for the production of high-quality therapeutic mRNAs.

Anne Houdusse-Juille

Team: Structural Motility Affiliation: Institut Curie, UMR144, Cell Biology and Cancer Presentation title: To be defined

Anne Houdusse, Ph.D. is a CNRS research director, head of the Structural Motility team of the Cell Biology and Cancer laboratory (CNRS/Institut Curie).

The focus of Anne Houdusse laboratory is on the study of nanomachines, these molecular motors that produce force within our cells, and which are essential for their dynamic organization, their ability to contract and migrate. From high-resolution structural knowledge, the challenge lies in identifying the precise role played by each of these motors when they participate in a cellular function in a coordinated manner. Most are also involved in many pathologies; understanding how to control their activity opens the way to new therapeutic solutions.

Anne Houdusse received the CNRS Bronze and Silver Medals and she was elected as an EMBO member in 2013.

Giorgio Seano

Team: Tumor Microenvironment Affiliation: Institut Curie, U1339 / UMR3666, Chemical Biology of Cancer Presentation title : To be defined

Giorgio Seano is a CNRS research director, head of the Tumor Microenvironment team of the Chemical Biology of Cancer unit.

Giorgio Seano’s research centers on brain tumors, with a particular focus on tumor plasticity, resistance mechanisms, and the tumor microenvironment. His lab studies how conventional therapies influence both cellular and microenvironmental plasticity. Using glioblastoma (GBM),a highly adaptable, therapy-resistant, and lethal brain tumor, as their primary model, they aim to uncover the role of tumor plasticity in treatment response.